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IMPAK TEKNIK KAUNSELING BERSTRUKTUR MELALUI AHLI 
FARMASI TERHADAP PENGETAHUAN, KEPUASAN, KUALITI HIDUP, 
PEMATUHAN DAN HASIL KLINIKAL PESAKIT ASMA DI HOSPITAL 




       Ahli farmasi dijangka memainkan peranan penting dalam pengurusan 
penyakit kronik. Kajian semasa menyasarkan matlamat dalam membangunkan suatu 
alat pembelajaran (buku kecil) dan menghuraikan kaunseling pengubatan berstruktur 
perantara ahli farmasi bagi pesakit asma. Ia juga menentukan impak intervensi ahli 
farmasi terhadap pengetahuan, kepuasan, kepatuhan terhadap pengubatan, kualiti 
hidup, hasil klinikal  (kadar alir ekspiratori puncak, PEFR), dan masalah berkaitan 
terapi drug (DTRP). Percubaan rawak terkawal telah dilakukan dengan 
memperuntuk pesakit-pesakit asma secara rawak sama ada kumpulan intervensi 
(n=37) atau kumpulan kawalan (n=38), menerima kaunseling pengubatan rutin di 
Jabatan Pesakit Luar, Klinik Dada, Hospital Raja Saud, Qassim, Arab Saudi. 
Daripada sejumlah 75 subjek, 58 (32 kawalan dan 26 intervensi) yang 
menyempurnakan kajian tersebut. Data demografi pesakit, pengetahuan mengenai 
asma, kualiti hidup, kepuasan, hasil klinikal dan DTRPs dinilai pada tahap asas dan 
selepas selesai 1,4, and 7 bulan, justeru, tempoh kajian adalah selama 7 bulan. 
Penemuan kajian menunjukkan peningkatan dalam pengetahuan dari 43.1% pada 
tahap asas kepada 67.2%, 81%, dan 84.5% pada susulan 1, 2, dan 3, masing-
masingnya. Walaubagaimanapun, diperhatikan bahawa skor kualiti hidup (QoL) 
pada kumpulan intervensi tidak menunjukkan sebarang peningkatan dari tahap asas 
ke susulan ke-1(p = 0.526), ke-2 (p = 0.155), dan susulan ke-3 (p = 0.242). Tahap 
xx 
 
kepuasan dalam kumpulan intervensi meningkat dengan ketara pada setiap susulan 
berbanding tahap asas (p = 0.005). Dalam kumpulan intervensi, terdapat peningkatan 
ketara dalam corak pematuhan pada tahap asas ke susulan ke-1 (p = 0.002), ke-2 (p < 
0.001) dan  ke-3 ( p = 0.005). Suatu perbezaan signifikan ketara dapat di lihat  dalam 
DTRP antara kumpulan-kumpulan intervensi dan kawalan pada susulan pertama 
(p<0.001) dan ketiga (p=0.005). Sama juga,  terdapat peningkatan ketara dalam skor 
DTRP pada kumpulan terkawal dari tahap asas ke susulan ketiga (p = 0.005) dan 
susulan pertama dan kedua  (p = 0.033). Namun demikian, keputusan 
mengambarkan peningkatan yang tak signifikan  dalam PEFR antara kedua-dua 
kumpulan ( intervensi, p = 0.064 dan kawalan , p = 0.891). Tambahan pula, utilisasi 
suplemen-suplemen herba dalam kedua-kedua kumpulan menurun dari tahap asas ke 
tahap ketiga pada lawatan susulan, dengan penurunan mendadak dalam kumpulan 
intervensi. Kesimpulannya, kajian ini menyediakan bukti tentang impak alat 
pembelajaran dan kaunseling pengubatan berstruktur perantara ahli farmasi dalam 
meningkatkan kemahiran pesakit, QoL, pematuhan, kepuasan pesakit-pesakit asma. 
Tambahan pula, kajian ini menyumbang pandangan dalam pelaksanaan praktis 













THE IMPACT OF A STRUCTURED COUNSELING TECHNIQUE BY 
PHARMACIST ON KNOWLEDGE, SATISFACTION, QUALITY OF LIFE, 
ADHERENCE AND CLINICAL OUTCOMES AMONG ASTHMA 
PATIENTS AT KING SAUD HOSPITAL, SAUDI ARABIA 
 
ABSTRACT 
The pharmacist is expected to play a vital role in chronic disease 
management. The present study aimed at developing an educational tool (booklet) 
and described a pharmacist--mediated structured medication counseling for 
asthmatic patients. It also determined the impact of pharmacist intervention on 
asthma patient’s knowledge, satisfaction, medication adherence, quality of life, 
clinical outcomes (peak expiratory flow rate, PEFR), and drug therapy-related 
problems (DTRPs). A randomized controlled trial compared the conventional routine 
counseling [control (n = 38)] with structured medication counseling provided by 
pharmacist [intervention (n = 37)] at the Outpatient Department of the Chest Clinic 
at King Saud Hospital, Qassim, Saudi Arabia. Out of 75 subjects, 58 (32 control and 
26 intervention group) completed the study. Patients’ demographic data, knowledge 
about asthma, quality of life, patient satisfaction, adherence, clinical outcomes, and 
DTRPs were assessed at baseline, and after completion of 1, 4, and 7 months, thus 
making the study period a total of 7 months. Research findings showed an 
improvement in knowledge from 43.1% at baseline to 67.2%, 81%, and 84.5% at 
follow-up 1, 2, and 3, respectively. However, it was observed that quality of life 
(QoL) scores in the intervention group did not improve from baseline to follow-up 1 
(p = 0.526), follow-up 2 (p = 0.155), and follow-up 3 (p = 0.242). The level of 
satisfaction in the intervention group were improved significantly at each follow-up 
xxii 
 
compared to baseline (p = 0.005). In the intervention group, there was significant 
improvement in adherence form baseline to first (p = 0.002), second (p < 0.001), and 
third (p < 0.001) follow-ups. A significant difference was noted in the DTRPs 
between the intervention and control groups at first (p < 0.001) and third (p = 0.005) 
follow-ups. Similarly, there was significant improvement in DTRP scores in follow-
ups control group from baseline to the third follow-up (p = 0.005) and from the first 
to the second follow-ups (p = 0.033). Nevertheless, the results revealed a non-
significant improvement in PEFR among both groups (intervention, p = 0.064 and 
control, p = 0.891). In addition, the utilization of herbal supplements in both groups 
dropped from the baseline to the third follow-up visit, with a higher reduction in the 
intervention group. In conclusion, the research provide evidence on the impact of the 
educational tool and pharmacist-mediated structured medication counseling in 
enhancing patients’ knowledge, QoL, adherence, satisfaction, and adherence for 
asthmatic patients. Furthermore, the research finding provides an insight into 







CHAPTER 1  
INTRODUCTION 
1.1  Introduction 
Asthma, a commonly prevalent disease in Saudi Arabia, is a common chronic 
respiratory condition worldwide and is characterized by reversible airway obstruction, 
airway inflammation and increased airway responsiveness to a variety of external and 
internal stimuli. These stimuli may be allergens, such as smoke, cold weather, exercise, 
certain drugs, and sometimes even psychological stress (Gibbs & Small, 2003), that 
could potentially trigger an asthma attack. Asthma affects people of all ages and patients 
with asthma usually present with typical symptoms that include wheezing, coughing, 
and tightness of the chest (Gibbs & Small, 2003). In addition, they may also have 
mucosal plugging and increased secretions of the tracheobronchial tree. 
            Saudi Arabia has an estimated population of approximately 26.1 million, of 
which 74.1% are native Saudis (Salam, 2013). The prevalence of asthma in Saudi 
Arabia is high and has been increasing in the recent past (Al Frayh, Shakoor, Gad El 
Rab, & Hasnain, 2001). Based on the available literature from the last three decades, Al-
Moamary et al. (2012) reported an alarmingly overall prevalence of 8%-25% among 
children, with an increased asthma incidence over time period. Based on findings from a 
household survey in 2013, the asthma prevalence among Saudi Arabian adult was 4.05% 
(Moradi-Lakeh et al., 2015). Evidence also suggests a strong link between asthma and 




Asthma is a chronic disease that requires specialized care and often lifelong 
medication; the level of care needed in asthma often go beyond care in the hospital and 
requiring specialized community care services from health professionals such as 
pharmacists. By the nature of the pathophysiology and disease prognosis, asthma 
requires both pharmacological and non-pharmacological therapies. The pharmacological 
treatment includes β2agonists (salbutamol, salmeterol and bambuterol), xanthine 
alkaloids (theophylline), anticholinergics (ipratropium), corticosteroids (prednisolone, 
budesonide, fluticasone, and beclomethasone), mast cell stabilizers (sodium 
cromoglycate), leukotriene-receptor antagonists (montelukast), and leukotriene-
synthesis inhibitors (zileuton) (Gibbs & Small, 2003); in addition, anti-immunoglobulin 
E therapy (omalizumab) has recently been tried for asthma patients. For chronic asthma 
management, the medications are administered directly into the lungs; hence, the patient 
must use certain specialized drug delivery systems, which may need a basic level of skill 
and understanding. It has been noted that asthma patients often do not know how to use 
these devices optimally, which can lead to poor clinical outcomes (De Oliveira, Bruno, 
Ballini, Brito,  & Fernandes, 1997; Lavorini et al., 2008; Plaza & Sanchis, 1998) 
resulting in impaired quality of life . In addition to the drug therapy, several non-
pharmacological measures are of great importance in better disease control in asthma 
patients, such as smoking cessation and avoidance of allergens. 
As asthma is a chronic disease often requiring lifelong treatment, the patient may 
not adhere to the physician’s advice and often may not take the medicines regularly. 
Similarly, improper use of inhalation devices is known to be one of the leading causes of 
therapeutic failure (Newman, Weisz, Talaee, & Clarke, 1991). The main reason for this 
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may be attributed to the poor hand-lung coordination which is critical while using these 
dosage forms. In addition, self-monitoring of treatment is essential in asthma so that the 
patient becomes actively involved in his or her own self-care, as well as a partner in 
disease management especially in using rescue medications (often salbutamol inhaler) 
appropriately.  
Pharmacists, as important healthcare professionals, are expected to play a vital 
role in chronic disease management (Lewis, Lasack, Lambert, & Connor, 1997). There 
have been several studies conducted around the world that have indicated the positive 
role and value of patient counseling by pharmacists in asthma management (Bynum, 
Hopkins, Thomas, Copeland, & Irwin, 2001; Cordina, McElnay, & Hughes, 2001; De 
Tullio & Corson, 1987; Odegard et al., 2004; Weinberger et al., 2002). Such counseling 
results in several benefits: it improves the patient’s understanding of his or her disease, 
the medication being taken, and the lifestyle modifications needed, as well as patient 
adherence and concordance (Hawkins, Fiedler, Dougles, & Eschbach, 1979). Patient 
counseling may also lead to better therapeutic outcomes and ultimately an improved 
quality of life (Kheir, Emmerton,  & Shaw, 2001). 
1.2 Conceptual framework 
The research mainly involved the provision of asthma-related counseling and 
care by pharmacists, and evaluating its impact on various outcomes: knowledge, clinical 
outcomes, adherence, satisfaction, quality of life (QoL), and minimizing drug therapy-
















Patient counseling is an important aspect of pharmaceutical care (PC) 
(McGivney et al., 2007), and it includes providing counseling and consultation to 
asthma patients. Asthma is managed using multiple therapeutic strategies with the goal 
of controlling the progression of the disease and preventing acute attacks. Several 
challenges reported in the management of asthma include patients’ poor understanding 
of the symptoms, inhaler techniques, use of alternative medications of unproven 
efficacies, improper management plans, and poor medical, and medication history 
available to the healthcare professionals. These factors result in inconsistency and 
variability in clinical decision-making and practice. 
PC aims to achieve definite outcomes that improve a patient’s QoL (Hepler & 
Strand, 1990). PC provided by the pharmacist can help the achievement of goals in the 
management of asthma through identifying triggers, considering medication history and 
medication reconciliation, and providing a properly considered therapeutic regimen 
Clinical 
outcomes Knowledge 
Booklet on the 











Counseling aids  
Satisfaction 
Figure 1.1.  Conceptual framework of the research 
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(such as through clinical management plans and asthma action plans), as well as 
educating the patient about the disease, medications, self-monitoring, and self-
management, administration techniques, and lifestyle modifications. Shanmugam et al. 
(2012) provided evidence about asthma control through PC and demonstrated its 
positive impact in improving patients’ asthma-related QoL, lung function, disease 
control, adherence to their preventive medication, and knowledge about the disease. 
During the course of counseling, the pharmacist must consider physical, 
psychological, socio-cultural, emotional, and intellectual perspectives, as well as respect 
the health beliefs and values of the patient (International Pharmaceutical Federation, 
2005). The Canadian Asthma Consensus Report (1999) stated that education for asthma 
patients should be aimed at altering patients’ behavior and achieving positive outcomes 
rather than simply providing knowledge. The report outlined the diverse range of 
educational strategies and methods that can be used, including counseling through 
individual teaching, small-group sessions, computer games, large-group lectures, 
checklists, video and audio tapes, workbooks and booklets, diaries, internet websites, 
problem-solving sessions, and repeated audits by health professionals (Boulet, Becker, 
Bérubé, Beveridge, & Ernst, 1999). Thus, there are a range of options from which the 
pharmacist can choose an appropriate counseling method. 
It is essential to provide verbal and written information to asthma patients in a 
manner they understand. This aspect of counseling could involve the use of 
appropriately designed counseling aids tailored to the patient requirements. While 
developing these aids, the educator (i.e., the counseling pharmacist) should give utmost 
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consideration to the literacy level, eyesight, and language of comfort of the target 
patient. The various medication aids that can help in achieving positive outcomes in 
asthma education include videos, pictograms, inhaler aids, medication cards, and an 
asthma symptom diary (International Pharmaceutical Federation, 2005). In this research, 
the authors used a locally designed patient information leaflet as the tool for efficient 
counseling. 
The present study focused on the development of a structured counseling 
technique for asthma counseling. This is important because, although there is a range of 
medication available for asthma, its prevalence is still increasing in Saudi Arabia (Al 
Frayh et al., 2001; Moradi-Lakeh et al., 2015). Thus, there is a need to explore options 
other than medication to improve the treatment outcomes of asthma patients among the 
Saudi population. There have been no previous studies documenting the role of 
structured patient counseling in asthma patients in Saudi Arabia. 
It is well documented that pharmacist-provided patient counseling improves 
therapeutic outcomes (this is described in greater detail in Section 2.3.3). Such 
improvement is dependent on patient’s knowledge and satisfaction with the treatment. 
Studies have documented that pharmacist counseling for asthma patients improves both 
their knowledge (Section 2.3.1) and their satisfaction (Section 2.3.4). Positive outcomes 
include a reduction in drug-related problems, better adherence, and improvement in the 
disease. A structured, systematic counseling technique, along with appropriate patient 
counseling and adequate use of educational aids, could improve clinical outcomes and 
thus, ensure a better control of disease and improved symptom-free interval and QoL. 
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1.3 Problem statement 
In order to improve their QoL and survival rate, asthma patients require 
continued medical care and patient education. Asthma patients who are able to access 
good quality pharmacist-provided asthma education and management services have 
shown improved disease outcomes over standard treatment, as well as improved control 
of their asthma (Boulet et al., 1999; International Pharmaceutical Federation, 2005; 
Kheir et al., 2001; Shanmugam et al., 2012). Although there is an association between 
poor knowledge and poor outcomes, there has been less number on controlled clinical 
trials to justify the strategies for improving knowledge and clinical outcomes. 
Despite the availability of a range of medication for asthma, the disease 
outcomes among asthma patients are often not encouraging and patient adherence is a 
major issue (Eakin and Rand, 2012).  This suggests the need for the development of 
alternative measures or approaches that could address poor clinical outcomes, and 
underlines the need to explore possible modification to delivery of drug therapy, 
dispensing of medications, patient counseling, and strategies to improve concordance 
and adherence. These requirements for disease management strongly support further 
development of PC plan for asthma patients. 
Often, patients with asthma are not well informed about their drug therapy and 
disease condition. This may lead to poor adherence to their treatment, which can 
ultimately lead to therapeutic failure and can therefore result in poor clinical outcomes 
and diminished QoL. 
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Physicians are often burdened with heavy patient loads and may focus their 
attention on the diagnosis of diseased patients and less emphasize on pharmacotherapy 
and lifestyle modifications. This means the role of pharmacist in providing care to 
institutionalized and ambulatory patients can be vital. 
Patient satisfaction is an important issue when delivering healthcare, and the role 
of the pharmacist in improving patient satisfaction needs consideration. The usefulness 
of pharmacists in improving the satisfaction level of asthma patients should therefore be 
explored. 
1.4 Research questions 
This study was based on the below research questions: 
1. What are the various drug therapy-related problems experienced by 
ambulatory patients with asthma? 
2. Can structured medication counseling provided by a pharmacist have an 
influence on knowledge, satisfaction, medication adherence, quality of 
life, DTRPs, and clinical outcome?  
1.5  Research hypothesis 
1.5.1  Null hypothesis 
The null hypothesis for this research was the following: There is no association 
between structured counseling provided by a pharmacist and the knowledge, 
satisfaction, adherence, QoL, DTRPs, and clinical outcomes of asthma patients. 
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1.5.2  Alternative hypothesis 
The alternative hypothesis to this was the following: There is an association 
between structured counseling provided by a pharmacist and the knowledge, 
satisfaction, adherence, QoL, DTRPs, and clinical outcomes of asthma patients. 
1.6  Objectives of the study 
1.6.1  General objective 
The general objective of this study was ‘to evaluate the impact of a pharmacist-
provided structured medication counseling technique on knowledge, satisfaction, 
adherence, QoL, DTRPs, and clinical outcomes among asthma patients’. 
1.6.2  Specific objectives 
The specific objectives of this study were as follows: 
1.  To develop an educational tool in the form of booklet for asthmatic 
patients. 
2.  To determine the impact of pharmacist-provided intervention on patients’ 
clinical outcomes, as measured using peak expiratory flow rate (PEFR). 
3.  To describe and determine the impact of pharmacist-provided 
intervention on the knowledge, satisfaction, and medication adherence of 
asthmatic patients. 




5.  To identify the types of drug therapy-related problems experienced by 
asthmatic patients. 
1.7  Significance of the research 
This research is one of the first in its type to be conducted in Saudi Arabia 
among asthma patients. It has the following significance: 
1.  It provides new clinical data about asthma patients in the Saudi Arabian 
population, including patient knowledge, satisfaction, QoL, adherence, DTRPs, 
and PEFR. These data could be useful for further research pertaining to asthma 
in the local population. 
2.  It could be adopted as a standard approach for counseling other chronic 
diseases in Saudi Arabia. The basis for asthma counseling in this study 
involved the development of a structured counseling program and the design of 
locally appropriate patient information leaflets. These concepts could potentially 
be adopted by pharmacists in providing care to patients suffering from other 
chronic diseases such as hypertension, diabetes, hyperlipidemia, thyroid 
dysfunction, or rheumatoid arthritis. Figure 1.2 outlines a proposed structured 


















3.  It creates a professional pharmacy practice role in helping Saudi asthmatic 
patients. This research supports the professional role of pharmacists in caring 
for patients suffering from asthma, thus providing the opportunity for 
pharmacists to be more patient-focused, as well as offering professional 
recognition of and justification for the valuable role pharmacists can play in 
chronic disease management. 
 
 
Figure 1.2. Structured counseling approaches for chronic disease management  
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CHAPTER 2  
LITERATURE REVIEW 
2.1  Search strategy for literature 
Papers for this chapter were collected by searching Google Scholar 
(www.scholar.google.com) using the search terms “pharmacist‟s intervention,” 
“structured approach,” “pharmacist-coordinated medication counseling,” 
“knowledge,” “satisfaction,” “adherence,” “counseling,” “quality of life” and 
“asthma,” and PubMed/Medline using the MeSH terms “pharmacists,” 
“pharmaceutical services,” “knowledge,” “adherence,” “satisfaction,” “asthma,” 
“quality of life” and “drug therapy related problems.” The papers selected were 
original articles that described an intervention among asthma patients and provided 
the results of that intervention in any of the following outcomes: knowledge, 
satisfaction, adherence, counseling, DTRPs, or QoL. In few cases, studies related to 
other chronic diseases were also reviewed. Priority was given to the most recent 
articles, and in cases where there have only been limited articles on a topic, the 
search period was extended to up to 15 years. In addition, a manual search was 
conducted among the various articles that were available to the researcher, including 
the Central Library of the Universiti Sains Malaysia, and relevant articles were 
segregated and reviewed. Articles published up to June 2016 were included. This 
chapter of the thesis briefly summarizes these articles by subject. 
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2.2  Pharmaceutical care 
2.2.1  Definition   
In 1990, Hepler and Strand gave the pharmacy profession a new dimension by 
introducing the concept and practice of “pharmaceutical care,” which they defined as 
“the responsible provision of drug therapy for the purpose of achieving definite 
outcomes which improve a patient‟s QoL” (Hepler & Strand, 1990). A further, more 
patient-centered approach was later provided by Linda Strand, who stated that PC is 
not only a theory but also a philosophy of practice (Strand, 1997). Carollo, Rieutord, 
and Launay-Vacher (2012) defined PC as “the pharmaceutical contribution to patient 
care in identifying PC issues (medications-related issues), and establishing and 
administering a PC plan.” 
The American Pharmacists Association described PC as “a patient-centered, 
outcomes-oriented pharmacy practice that requires the pharmacist to work in concert 
with the patient and the patient‟s other healthcare providers to promote health, to 
prevent disease, and to assess, monitor, initiate, and modify medication use to assure 
that drug therapy regimens are safe and effective”. The goal of PC is to optimize the 
patient‟s QoL, and to achieve positive clinical outcomes within realistic economic 
expenditures (McLean, Gillis, & Waller, 2003). 
Recently in 2013, the board of the Pharmaceutical Care Network Europe 
(PCNE) redefined PC as “the pharmacist‟s contribution to the care of individuals in 




2.2.2  Pharmaceutical care for asthma 
As asthma is a chronic condition requiring lifelong medication, it is essential 
for patients to obtain counseling and care from their pharmacists. Several studies 
have demonstrated the usefulness of PC in asthma management. Many studies are 
mentioned in this section and others are described in Section 2.3. 
Mangiapane et al. (2005) conducted an interventional study to assess the 
effectiveness of a PC program on clinical, patient-related, and economic outcomes of 
asthma patients. The study enrolled 55 asthma patients with 550 matched controls to 
compare the data of various subgroups of the intervention group with those of the 
control group. The study demonstrated improved QoL scores in the intervention 
group, as well as improvements in other patient-related outcomes (knowledge scores 
and adherence). The clinical outcomes also improved significantly in the intervention 
group. The study could not evaluate the effectiveness of the program with regard to 
economic outcomes; patients with more severe asthma may be required for such an 
evaluation (Bunting & Cranor, 2003). 
A study by Taylor, Byrd, and Krueger (2003) assessed the effect of PC on the 
prevention, detection, and resolution of medication-related problems in Alabama, 
United States of America (USA). This was a case-control interventional study that 
enrolled 69 patients. Of these, 33 patients were in the intervention group that was 
provided with a PC plan that included drug and disease information, identifying and 
solving DTRPs, and monitoring the patient‟s response to the medications. This study 
showed that medication adherence scores improved in the intervention group. In 
addition, the participants‟ knowledge about the medications improved, and the 
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number of hospitalizations and visits to emergency departments decreased in the 
intervention group. 
In a prospective controlled multicenter study conducted in community 
pharmacies in Denmark (Herborg et al., 2001), the effect of therapeutic outcomes 
monitoring, a community-based program for PC regarding some asthma-related 
outcomes, was evaluated. The study included 500 asthma patients; patients in the 
intervention group were provided with therapeutic outcomes monitoring, which 
identified and resolved the patients‟ drug-related problems. Beneficial effects on 
knowledge about asthma and their medications were found among the patients in the 
intervention group when compared to the control group. Other outcomes such as 
days of sickness, disease-related symptoms, and QoL also improved in patients in the 
intervention group (Herborg et al., 2001). 
In a randomized controlled cluster design study by Volume et al. (2001), 
patient-related outcomes of asthma patients provided with PC were compared to 
those of patients who only received traditional pharmacy care. The study was carried 
out in 16 community pharmacies in Canada. The study showed that successful 
implementation of PC services helped improve patients‟ satisfaction with pharmacy-
related activities. No significant improvement was seen in QoL or patient adherence 
in the two groups compared to baseline. 
2.3 Pharmacist-provided patient counseling for asthma and its impact 
The literature related to the impact of pharmacist-provided patient counseling 




2.3.1  Impact of pharmacist counseling on patient knowledge in asthma 
Prior to reviewing the literature on the effect of PC on asthma patients, an 
attempt was made to critically review studies that evaluated various outcomes among 
individuals other than asthma patients. This revealed that pharmacists and school 
teachers lack adequate knowledge about asthma. Knowledge about asthma is 
important for individuals other than patients such as pharmacists (Corpas et al., 2006; 
Osman, Ahmed, & Ibrahim, 2012), school teachers (Ones, Akcay, Tamay, Guler, & 
Dogru, 2006) and caregivers (Rastogi, Madhok, & Kipperman, 2013). Pharmacists 
hold a responsible position in hospitals and the community in which they provide 
information about the disease, and about medications and interventions useful for 
asthma. Similarly, students suffering from asthma are sometimes taken care of by 
schoolteachers. 
A cross-sectional study in Sudan by Osman, Ahmed Hassan, and Ibrahim. 
(2012) evaluated the knowledge and skills of 300 community pharmacists regarding 
inhaler devices. The findings revealed that more than half of the pharmacists did not 
know all the steps involved in the inhalation technique for a metered-dose inhaler, 
the majority of the pharmacists did not know the proper technique for using the dry 
powder inhalers Turbuhaler® and Diskus®, and some had not even heard the name 
of such devices. This finding suggests that even pharmacists in developing countries 
lack adequate knowledge about inhalers and inhalation techniques. 
A pretest–posttest interventional study by Corpas et al. (2006) assessed 
changes in knowledge of asthma among 79 pharmacists. A workshop (a single 
theory-practice session that lasted 3 hours and 40 minutes) was conducted as an 
intervention. The greatest change in the pretest and posttest scores was observed 
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among those who had lower test scores. The difference was statistically significant, 
but the results depended on the participants‟ prior knowledge about asthma prior to 
attending the workshop. 
Knowledge of asthma among primary school teachers was assessed in Turkey 
(Ones et al., 2006). A questionnaire was administered to 792 teachers from 73 
randomly selected schools. The level of knowledge of schoolteachers about the signs, 
symptoms, and treatment of asthma, as well as the nature of the disease was 
satisfactory, with a mean score of 96.7 ± 19.8 out of a maximum possible score 130 
(74.3%). The authors concluded that there was a need for schoolteachers to 
understand about asthma and its impact so that the needs of asthmatic students can be 
met at the school in which they study. 
An interventional study by Rastogi, et al., (2013) in New York City involved 
268 caregivers. The intervention involved asthma education consisting of asthma 
pathophysiology, known indoor and outdoor asthma triggers, and the role and use of 
medications to control asthma. The study showed that the intervention group 
demonstrated a good retention of knowledge following one day of educational 
sessions, and that the number of visits to emergency departments was lower in this 
group than in the control group in the two years following the intervention. 
Studies that assessed knowledge about asthma among patients were also 
reviewed. These showed that many asthma patients had poor knowledge about the 
disease and the medications they used. They also revealed the importance of patient 
education, particularly through pharmacist-provided intervention, i.e., PC that 
included information about disease and medications, inhalation techniques, self-
management plans, and medication counseling. 
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Omole and Ilesanmi (2010) from Nigeria enrolled 73 asthma patients and 
found that asthma education strategies were important for improving patient 
outcomes. The researchers administered a structured interview using a questionnaire 
with the objective of determining the level of adherence of patients to anti-asthmatic 
medications. The study found that poor knowledge, suboptimal inhalation device 
technique, and a low level of adherence was prevalent among asthma patients. The 
study focused on the need for asthma education strategies among the patients with a 
low level of asthma knowledge to improve patient outcomes. 
A prospective, randomized, controlled study in Sudan by Abdelhamid, Awad, 
and Gismallah (2008) assessed the impact of hospital-based pharmaceutical services 
on asthma patients. Of 100 subjects, 60 were assigned to the intervention group and 
received comprehensive medication counseling and asthma education (about the 
disease, life style modifications, pharmacotherapy, self-management, and inhalation 
technique) every two weeks. The study showed a significantly greater improvement 
in the patients‟ knowledge about asthma in the intervention group, as well as a 
significant reduction in acute asthma attacks, nocturnal asthma attacks and the 
frequency of using β2 agonists, when compared to the control group. However, the 
follow-up period was too short to observe the long-term impact of the intervention. 
Reliance on self-documentation was another limitation of the study. 
A case-control interventional study by Al-Rashed, Wright, Roebuck, Sunter, 
and Chrystyn (2002) assessed the value of inpatient pharmaceutical counseling in 83 
patients. Pharmacist counseling (a 30-minute session for each patient) was provided 
as an intervention. The major findings of the study were that the patients‟ knowledge 
about their prescribed medicines improved, and there were fewer visits to their 
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physician and hospital admissions compared with before the intervention. However, 
the sample population was not large enough to generalize the results of the study. 
A randomized, controlled, parallel group trial was conducted by Mehuys et 
al. (2008) involving 201 asthma patients. Of these, 107 were assigned to the 
intervention group and received information about asthma and its pharmacological 
and non-pharmacological treatments in the first session, and a protocol-defined 
intervention (the Asthma Control Test, ACT) in the first and second follow-ups. The 
percentage of patients with correct inhalation technique increased in the intervention 
group; however, no significant improvement was seen in knowledge scores. 
Adherence to asthma control medications was also higher in the intervention group 
but no significant difference in Asthma Quality of Life Questionnaire (AQLQ) score 
was seen between the two groups. The limitations of this study were that it did not 
include any steroid-naïve patients but only included patients who had used chronic 
asthma medications for more than a year and who were regular pharmacy customers, 
so the results may not be generalizable to the wider population. 
A parallel, controlled design study by Saini, Krass, and Armour (2004) 
involving 102 asthma patients, assessed the impact of the service provided by 
community pharmacies to asthma patients with regard to clinical, patient-related, and 
economic outcomes. The intervention group (52 patients) was provided with 
specialized services based on an asthma care model with three follow-up visits over 6 
months. This resulted in a statistically significant improvement in asthma-related 
knowledge in the intervention group compared with the patients of the control group. 
Barthwal, Katoch, and Marwah (2009) conducted a non-randomized 
prospective trial that enrolled 172 patients and evaluated the impact of an asthma 
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education program on asthma morbidity, inhaler technique, and asthma knowledge. 
The program involved information about the disease and medications, self-
monitoring, regular medical reviews, and a written action plan. After the program, 
the number of patients with satisfactory knowledge score increased from 13.9% to 
69.7%. Other outcomes such as asthma morbidity and inhalation technique also 
improved. 
A randomized, controlled trial conducted over a period of 6 months by 
Schacher, Dhein, Münks-Lederer, Vollmer, and Worth (2006) evaluated the 
effectiveness of a structured outpatient education program among asthma patients. Of 
a total of 120 patients, 78 were assigned to the intervention group and were provided 
with an education program which included peak flow meter-controlled self-
medication, the correct use of medications, and detailed information about the 
disease and its treatment. The remaining patients formed the control group and were 
provided with a short education program on inhalation technique and the use of peak 
flow meter. The intervention group showed significantly improved knowledge of the 
disease compared to the control group, as well as an improvement in QoL scores and 
the number of patients who self-managed their asthma attacks. 
A similar randomized, controlled study by Wang, Chian, Lai, Tarn, and Wu 
(2010) enrolled 91 patients and evaluated the impact on asthma-related clinical and 
health outcomes of an education program on asthma provided by nursing personnel, 
and asthma counseling provided by a pharmacist showed a significant increase in the 
knowledge scores in the first and second groups compared to the control group, but 
no significant difference in adherence was found between the three groups. 
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2.3.2  Impact of pharmacist counseling on adherence by asthma patients 
An open, controlled, prospective, parallel study conducted in Brazil by Santos 
et al. (2010) enrolled 55 asthma patients to assess treatment adherence and the use of 
inhalation medications. The intervention group (28 patients) received counseling at 
three visits, whereas the control group received counseling only on the first visit. The 
inhalation technique scores were satisfactory for both groups at the first visit, the 
quality of inhalation technique improved and satisfactory scores were obtained by the 
intervention group after the counseling sessions at the next two visits. 
A randomized, controlled study by Cote et al. (2001) included 98 asthma 
patients and assessed the impact of two different educational interventions for adult 
patients. The patients in the intervention group were divided into two subgroups. The 
first subgroup received teaching about inhaler technique and a self-action plan 
provided by a physician; the second subgroup received the same as the first group 
plus a structural educational program on self-capacity for managing exacerbations. A 
significant improvement between the first and third visits in adherence for inhaled 
corticosteroids was seen only in the second intervention subgroup; however, there 
was a similar percentage increase in the prescription of inhaled corticosteroids in all 
three groups. Other patient outcomes (knowledge, QoL, and lung function) also 
improved in the second intervention subgroup compared to the first intervention 
subgroup and controls. 
A prospective, observational study in France enrolled 727 asthma patients 
and evaluated the effect of inhaler training provided by pharmacists on the patients‟ 
use of pressurized and breath-actuated metered-dose inhalers (MDIs) (Giraud 
Allaert, & Roche, 2011). The percentage of patients with optimal inhaler technique 
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increased from 24% to 79% and adherence also improved. However, a lack of 
randomization, the short period of observation, and the short duration of follow-up (1 
month) were some of the limitations of the study. 
Armour et al. (2007) conducted a multisite randomized intervention study to 
assess the impact of PACP in 396 asthma patients. The intervention included targeted 
counseling, as well as education about the condition, medication and lifestyle issues 
(such as trigger factors), a review of inhaler technique, an assessment of adherence, 
an investigation of whether there were any drug-related problems, goal setting and 
review, and referral to a GP as appropriate (e.g., for a change in medication or dose). 
The intervention group demonstrated improved adherence to the prevention 
medications and improvements in other patient outcomes (knowledge, QoL, etc.). 
In a randomized, controlled cluster design study by Volume, Farris, Kassam, 
Cox, and Cave (2001), the humanistic outcomes of asthma patients who received PC 
were compared to those of patients who only received traditional pharmacy care. The 
study was carried out in 16 community pharmacies in Canada in which the 
intervention group was provided with PC services. No significant improvement was 
seen in QoL and patient adherence in the two groups, but the study showed that 
successful implementation of PC services helped to improve patients‟ satisfaction 
with pharmacy-related activities. 
In addition to the aforementioned studies, there were studies by Al-Rashed et 
al. (2002), Mangiapane et al. (2005) and Mehuys et al. (2008), as discussed in 




Patient adherence is one of the important parameters that requires the pharmacist‟s 
intervention, as revealed by the studies described. These studies showed that many 
patients have low adherence to their treatment. They also demonstrated that patient 
education or PC that provides information about the disease, medications, and 
inhalation technique is an important tool in improving the adherence of asthma 
patients. 




An interventional study carried out by Diamond and Chapman (2001) in 
community pharmacies across Canada enrolled 4,080 asthma patients to evaluate the 
impact of nationally coordinated, pharmacy-based educational intervention on 
asthma control. The educational needs of each individual patient were assessed and 
appropriate education offered to them. The study showed that the pharmacy-based 
intervention helped in relieving daytime asthma symptoms, and reduced the 
frequency of nocturnal symptoms and the use of short-acting β2 agonists. A 
limitation of the study was that it included some patients with excessive health care 
use for asthma control; in such cases, pharmacy-based intervention may not be the 
only reason for the change in their clinical outcomes. 
A case-control interventional study by Magar et al. (2005) enrolled 238 
asthma patients and evaluated the impact of patient education programs on these 
patients. Patients in the intervention group were provided with a self-management 
program, and training sessions on the symptoms of the disease and peak expiratory 
flow. This group exhibited a significant improvement in a number of clinical 
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outcomes such as symptom-free days, number of times woken at night, consumption 
of corticosteroids, consumption of β2 agonists and QoL score. 
Barthwal et al. (2009), as mentioned in the Section 2.3.1, conducted a non-
randomized, prospective trial that included 172 patients to evaluate the impact of an 
asthma education program on asthma morbidity, inhaler technique, and asthma 
knowledge. The education program involved information about the disease and 
medications, as well as self-monitoring, regular medical reviews, and a written action 
plan. Following the education program, there was a significant decline in the number 
of moderate and severe persistent asthma attacks, the number of hospital visits, and 
the number of patients experiencing limitation to physical activity.   
Shanmugam et al. (2012) evaluated the outcome of PC service for 66 asthma 
patients. Patients in the intervention group received PC that included asthma 
education, medications counseling, lifestyle modification instructions, and an asthma 
care diary. The study concluded that the PC program helped to achieve the desired 
health outcomes as there was an improvement in the patients‟ lung function, asthma 
control, and asthma-related QoL. 
A randomized controlled study by Wang et al. (2010), as mentioned in 
Section 2.2.2 investigated the impact on asthma-related clinical and health outcomes 
of an education program about asthma provided by nurses, and counseling on asthma 
provided by a pharmacist. The 91 patients were divided into three groups; the first 
group received the nurse-administered educational program, the second group 
received the pharmacist-provided asthma counseling and the third group acted as the 
control group. There was a significant improvement in health outcomes in the 
